CRISPR Therapeutics AG Liquidation Value
CRSP
Other
Cash & Equivalents
$347.56M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $347.56M
Total Obligations: -$355.87M
$-8.31M
Per share: $-0.09
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $347.56M
AR: $0
Total Obligations: -$355.87M
$-8.31M
Per share: $-0.09
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $347.56M
AR: $0
Inventory: $0
Total Obligations: -$355.87M
$-8.31M
Per share: $-0.09
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-8.31M | $-0.09 |
| Liquid Liquidation Value | $-8.31M | $-0.09 |
| Operating Liquidation Value | $-8.31M | $-0.09 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $347.56M |
| Accounts Receivable | $0 |
| Inventory | N/A |
| Current Liabilities | $149.12M |
| Long-term Debt | N/A |
| Op. Lease Liability | $206.75M |
| Finance Lease | N/A |
| Shares Outstanding | 95.9M |
Explore all 176 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $347.56M | $0 | N/A | $11.14M | $149.12M | N/A | $206.75M | N/A |
| 2025-09-30 | $286.50M | $0 | N/A | $11.80M | $118.96M | N/A | $211.02M | N/A |
| 2025-06-30 | $193.62M | $0 | N/A | $9.75M | $104.36M | N/A | $215.45M | N/A |
| 2025-03-31 | $235.18M | $0 | N/A | $13.06M | $119.45M | N/A | $219.36M | N/A |
| 2024-12-31 | $298.26M | $25.00M | N/A | $14.71M | $87.78M | N/A | $223.69M | N/A |
| 2024-09-30 | $225.67M | $0 | N/A | $15.58M | $89.81M | N/A | $227.54M | N/A |
| 2024-06-30 | $484.47M | $0 | N/A | $9.45M | $127.82M | N/A | $231.30M | N/A |
| 2024-03-31 | $707.43M | $0 | N/A | $16.46M | $118.99M | N/A | $234.93M | N/A |
▼ Community Notes